¼¼°èÀÇ »ýüÀûÇÕÀç·á ½ÃÀå
Biocompatible Materials
»óǰÄÚµå : 1528117
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2024³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 199 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,209,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,629,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

»ýüÀûÇÕÀç·á ¼¼°è ½ÃÀåÀº 2030³â±îÁö 5,022¾ï ´Þ·¯¿¡ µµ´Þ

2023³â¿¡ 1,802¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â »ýüÀûÇÕÀç·á ¼¼°è ½ÃÀåÀº ºÐ¼® ±â°£ÀÎ 2023-2030³â¿¡ CAGR 15.8%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 5,022¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ Æú¸®¸Ó Àç·á´Â CAGR 17.0%¸¦ ³ªÅ¸³»°í, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 2,310¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±Ý¼Ó Àç·á ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£Áß CAGR 14.4%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 480¾ï ´Þ·¯, Áß±¹Àº CAGR 14.5%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ »ýüÀûÇÕÀç·á ½ÃÀåÀº 2023³â¿¡ 480¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 748¾ï ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2023-2030³â°£ CAGRÀº 14.5%ÀÔ´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î¼­´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£Áß CAGRÀº °¢°¢ 14.5%¿Í 13.3%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 11.0%¸¦ ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù.

¼¼°è »ýüÀûÇÕ¼º Àç·á ½ÃÀå - ÁÖ¿ä µ¿Çâ ¹× ÃËÁø¿äÀÎ ¿ä¾à

»ýüÀûÇÕÀç·á¶õ ¹«¾ùÀ̸ç, ¾î¶»°Ô ÀÇ·á¿¡ Çõ¸íÀ» ÀÏÀ¸Å°°í Àִ°¡?

»ýüÀûÇÕÀç·á´Â ÀÎü¿¡ ¹«ÇØÇÑ ¹æ½ÄÀ¸·Î »óÈ£ ÀÛ¿ëÇϵµ·Ï ¼³°èµÇ¾î ÀÇ·á¿ë ÀÓÇöõÆ®, ÀåÄ¡ ¹× º¸Ã¶¹°ÀÇ ¼º°ø¿¡ ÇʼöÀûÀÎ ¿ä¼ÒÀÔ´Ï´Ù. ÀÌ·¯ÇÑ Àç·á´Â ¾ö°ÝÇÑ ¾ÈÀü ±âÁØÀ» ÃæÁ·ÇØ¾ß Çϸç, À¯ÇØÇÑ ¸é¿ª ¹ÝÀÀ, °¨¿°, µ¶¼º ¾øÀÌ º»·¡ÀÇ ±â´ÉÀ» ¼öÇàÇÒ ¼ö ÀÖµµ·Ï º¸ÀåÇØ¾ß ÇÕ´Ï´Ù. ÀϹÝÀûÀÎ »ýüÀûÇÕ¼º Àç·á¿¡´Â ÀÇ·á¿ëÀ¸·Î Àû¿ë °¡´ÉÇÑ Æ¯Á¤ °íºÐÀÚ, ±Ý¼Ó, ¼¼¶ó¹Í, õ¿¬ ¹°ÁúÀÌ Æ÷ÇԵ˴ϴÙ. ¿¹¸¦ µé¾î, ƼŸ´½Àº °­µµ, ³»±¸¼º, ü³»¿¡¼­ ºÎ½ÄµÇÁö ¾Ê´Â ³ôÀº »ýü ÀûÇÕ¼ºÀ¸·Î ÀÎÇØ »À ÀÓÇöõÆ® ¹× Àΰø °üÀý¿¡ ³Î¸® »ç¿ëµË´Ï´Ù. ¸¶Âù°¡Áö·Î ½Ç¸®ÄÜ °í¹«´Â À¯¿¬¼º°ú ºÒȰ¼º Ư¼ºÀ¸·Î ÀÎÇØ ÀÓÇöõÆ® ¹× Ä«Å×ÅÍ¿¡ ¼±È£µÇ°í ÀÖ½À´Ï´Ù. »ýüÀûÇÕÀç·áÀÇ °³¹ßÀº ÀÇ·á±â±âÀÇ ¼ö¸í°ú ±â´ÉÀ» Çâ»ó½Ã۰í ȯÀÚÀÇ »îÀÇ ÁúÀ» Çâ»ó½ÃÄÑ¾ß ÇÒ Çʿ伺¿¡ ÀÇÇØ ÃßÁøµÇ°í ÀÖ½À´Ï´Ù.

÷´Ü ±â¼úÀº »ýüÀûÇÕÀç·á¸¦ ¾î¶»°Ô °­È­Çϴ°¡?

³ª³ë±â¼ú, »ý¸í°øÇÐ, Àç·á°úÇÐÀÇ ºñ¾àÀûÀÎ ¹ßÀüÀ¸·Î »ýüÀûÇÕÀç·á ºÐ¾ß´Â ºü¸£°Ô ¹ßÀüÇϰí ÀÖ½À´Ï´Ù. ¿¬±¸ÀÚµéÀº ÀÌÁ¦ ºÐÀÚ ¼öÁØ¿¡¼­ Àç·á¸¦ ¼³°èÇÏ°í ±× Æ¯¼ºÀ» ƯÁ¤ ÀÇ·á ¿ëµµ¿¡ ¸Â°Ô Á¶Á¤ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ´Ù·®ÀÇ ¹°À» Èí¼öÇÏ´Â °íºÐÀÚ·Î ¸¸µç ÇÏÀ̵å·Î°ÖÀº ¼ÒÇÁÆ® ÄÜÅÃÆ®·»Áî¿Í »óó Ä¡À¯¸¦ ÃËÁøÇÏ´Â »óó µå·¹½ÌÀ» ¸¸µå´Â µ¥ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Ç¥¸é °³Áú ±â¼úÀ» ÅëÇØ °úÇÐÀÚµéÀº Àç·á¿Í »ý¹°ÇÐÀû ȯ°æÀÇ »óÈ£ÀÛ¿ëÀ» °­È­ÇÏ¿© ÀÓÇöõÆ®¿Í »ýü Á¶Á÷°úÀÇ ÅëÇÕÀ» Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù. »ýºÐÇØ¼º Àç·á¿Í °°Àº ±â¼ú Çõ½ÅÀº ÀÓÇöõÆ®¿Í °ü·ÃµÈ Àå±âÀûÀÎ À§ÇèÀ» ÁÙÀÏ ¼ö ÀÖ´Â °¡´É¼ºÀ» º¸¿©ÁÖ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Àç·á´Â Á¡ÁøÀûÀ¸·Î ¿ëÇØµÇ¾î ü³»¿¡¼­ Èí¼öµÇ°Å³ª ¹è¼³µÇ±â ¶§¹®¿¡ ÀÓÇöõÆ®°¡ ¸ñÀûÀ» ´Þ¼ºÇÑ ÈÄ ¿Ü°úÀûÀ¸·Î Á¦°ÅÇÒ Çʿ䰡 ¾ø±â ¶§¹®ÀÔ´Ï´Ù.

ÀÓ»ó ÀÀ¿ë¿¡¼­ »ýüÀûÇÕÀç·á°¡ Á÷¸éÇÑ °úÁ¦´Â?

»ýüÀûÇÕÀç·á´Â Çõ½ÅÀûÀÎ ÀáÀç·ÂÀ» °¡Áö°í ÀÖÁö¸¸, ÀÓ»ó Àû¿ë¿¡ ÀÖ¾î ¸î °¡Áö µµÀü°úÁ¦°¡ ÀÖ½À´Ï´Ù. Àΰ£ÀÇ »ý¹°ÇÐÀº º¹ÀâÇϱ⠶§¹®¿¡ Àç·á°¡ ü³»¿¡¼­ ¾î¶² ÇൿÀ» º¸ÀÏÁö ¿¹ÃøÇÏ´Â °ÍÀº ¸Å¿ì º¹ÀâÇÑ ÀÏÀÔ´Ï´Ù. ¸é¿ª ¹ÝÀÀ, »ýü ºÎ½Ä, Àå±â ¾ÈÁ¤¼º µîÀº ¿¬±¸ÀÚµéÀÌ ÇØ°áÇØ¾ß ÇÒ Áß¿äÇÑ ¹®Á¦ Áß ÇϳªÀÔ´Ï´Ù. ¿¹¸¦ µé¾î, ºÎ½ÄµÈ ÀÓÇöõÆ®¿¡¼­ ³ª¿À´Â ±Ý¼Ó ÀÌ¿ÂÀº ü³»¿¡ ÃàÀûµÇ¾î ±Ý¼Ó µ¶¼º ¹× ¾Ë·¹¸£±â ¹ÝÀÀÀ» À¯¹ßÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, »õ·Î¿î »ýüÀûÇÕ¼º Àç·á¸¦ °³¹ßÇϰí Å×½ºÆ®ÇÏ´Â µ¥ µå´Â ºñ¿ëÀº ¾öû³ª°Ô ³ôÀ» ¼ö ÀÖÀ¸¸ç, ¾ÈÀü¼º°ú À¯È¿¼º ±âÁØÀ» ÃæÁ·ÇÏ´ÂÁö È®ÀÎÇϱâ À§ÇØ ´ë±Ô¸ð ÀüÀÓ»ó ¹× ÀÓ»ó½ÃÇèÀÌ ÇÊ¿äÇÑ °æ¿ì°¡ ¸¹½À´Ï´Ù. ÀÌ·¯ÇÑ µµÀüÀº Àç·á °úÇÐÀÚ, ¿£Áö´Ï¾î ¹× ÀÇ·á Àü¹®°¡µéÀÇ Áö¼ÓÀûÀÎ ¿¬±¸¿Í Çù·ÂÀ» ÇÊ¿ä·Î Çϸç, »õ·Î¿î °³¹ßÀÌ ¾ÈÀüÇϰí È¿°úÀûÀ¸·Î ÀÓ»ó¿¡ Àû¿ëµÉ ¼ö ÀÖµµ·Ï ÇØ¾ß ÇÕ´Ï´Ù.

»ýüÀûÇÕ¼º Àç·á ½ÃÀåÀÇ ¼ºÀå ¿øµ¿·ÂÀº?

»ýüÀûÇÕÀç·á ½ÃÀåÀÇ ¼ºÀåÀº º¸´Ù Á¤±³Çϰí È¿°úÀûÀÎ Á¦Ç°À» °³¹ßÇÒ ¼ö ÀÖ´Â ±â¼ú ¹ßÀü µî ¿©·¯ ¿äÀο¡ ±âÀÎÇÕ´Ï´Ù. ¶ÇÇÑ, °ñ°üÀý¿°, ½ÉÇ÷°ü Áúȯ°ú °°Àº ¸¸¼º ÁúȯÀÇ À¯º´·ü Áõ°¡´Â Àå±âÀûÀÎ À̽ÄÇü ÀåÄ¡³ª ¼ö¼úÀû °³ÀÔÀÌ ÇÊ¿äÇÑ °æ¿ì°¡ ¸¹±â ¶§¹®¿¡ ¼¼°è Àα¸ÀÇ °í·ÉÈ­¿Í ÀÌ¿¡ µû¸¥ ¸¸¼º ÁúȯÀÇ À¯º´·ü Áõ°¡µµ Å« ¼ºÀå ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÃÖ¼Òħ½À ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ´õ ÀÛÀº Àý°³Ã¢À¸·Î ¼ö¼úÀÌ °¡´ÉÇϰí ȸº¹ ½Ã°£ÀÌ Âª°í °¨¿° À§ÇèÀ» ÁÙÀÏ ¼ö ÀÖ´Â »ýüÀûÇÕ¼º Àç·áÀÇ »ç¿ëÀ» ÃËÁøÇÒ °ÍÀÔ´Ï´Ù. ¼ÒºñÀÚ Çൿµµ º¯È­Çϰí ÀÖÀ¸¸ç, »ýüÀûÇÕ¼º Àç·á°¡ Á¦°øÇÒ ¼ö ÀÖ´Â ¼ö¸í»Ó¸¸ ¾Æ´Ï¶ó »îÀÇ ÁúÀ» Çâ»ó½Ãų ¼ö ÀÖ´Â Ä¡·á¹ýÀ» ã´Â ȯÀÚ°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½ÅÈï ½ÃÀå¿¡¼­ »ýüÀûÇÕÀç·á¿¡ ´ëÇÑ ±ÔÁ¦ ´ç±¹ÀÇ Áö¿øÀº »õ·Î¿î ÀÇ·á ±â¼ú¿¡ ´ëÇÑ Á¢±Ù¼ºÀ» È®´ëÇÏ¿© »ê¾÷ ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀÌ º¹ÇÕÀûÀ¸·Î ÀÛ¿ëÇÏ¿© »ýüÀûÇÕ¼º Àç·á ½ÃÀåÀº Áö¼ÓÀûÀ¸·Î È®´ëµÇ°í ÀÖÀ¸¸ç, ´Ù¾çÇÑ ÀÇ·á ÀÀ¿ë ºÐ¾ß¿¡ ÇʼöÀûÀÎ ¼Ö·ç¼ÇÀ» Á¦°øÇÕ´Ï´Ù.

Á¶»ç ´ë»ó ±â¾÷ ¿¹(ÃÑ 53°Ç)

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Biocompatible Materials Market to Reach US$502.2 Billion by 2030

The global market for Biocompatible Materials estimated at US$180.2 Billion in the year 2023, is expected to reach US$502.2 Billion by 2030, growing at a CAGR of 15.8% over the analysis period 2023-2030. Polymeric Material, one of the segments analyzed in the report, is expected to record a 17.0% CAGR and reach US$231.0 Billion by the end of the analysis period. Growth in the Metallic Material segment is estimated at 14.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$48.0 Billion While China is Forecast to Grow at 14.5% CAGR

The Biocompatible Materials market in the U.S. is estimated at US$48.0 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$74.8 Billion by the year 2030 trailing a CAGR of 14.5% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 14.5% and 13.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 11.0% CAGR.

Global Biocompatible Materials Market - Key Trends and Drivers Summarized

What Are Biocompatible Materials and How Are They Revolutionizing Medicine?

Biocompatible materials are engineered to interact with the human body in ways that are not harmful, making them integral to the success of medical implants, devices, and prosthetics. These materials must meet rigorous safety standards, ensuring that they perform their intended functions without causing adverse immune reactions, infections, or toxicity. Common biocompatible materials include certain polymers, metals, ceramics, and natural substances that can be adapted for medical applications. For instance, titanium is widely used for bone implants and joint replacements due to its strength, durability, and high biocompatibility, as it does not corrode inside the body. Similarly, silicone rubber is favored for implants and catheters because of its flexibility and inert properties. The development of biocompatible materials is driven by the need to enhance the longevity and functionality of medical devices and improve the quality of life for patients.

How Are Advanced Technologies Enhancing Biocompatible Materials?

The field of biocompatible materials is advancing rapidly, thanks to breakthroughs in nanotechnology, biotechnology, and material science. Researchers are now able to design materials at the molecular level, tailoring their properties to specific medical applications. For example, hydrogels made from polymers that can absorb significant amounts of water are being used to create soft contact lenses and wound dressings that promote healing. Additionally, surface modification techniques allow scientists to enhance the interaction between the material and the biological environment, improving the integration of implants with body tissues. Innovations such as biodegradable materials also show promise for reducing the long-term risk associated with implants, as these materials can gradually dissolve and be absorbed or excreted by the body, eliminating the need for surgical removal after they have served their purpose.

What Challenges Do Biocompatible Materials Face in Clinical Applications?

While biocompatible materials have transformative potential, their clinical application comes with several challenges. The complexity of human biology means that predicting how materials will behave inside the body can be incredibly complex. Immune response, bio-corrosion, and long-term stability are among the significant concerns that researchers must address. For example, metal ions from corroding implants can accumulate in the body and potentially lead to metal toxicity or allergic reactions. Furthermore, the cost of developing and testing new biocompatible materials can be prohibitively high, often necessitating extensive preclinical and clinical trials to ensure they meet safety and efficacy standards. These challenges require ongoing research and collaboration between material scientists, engineers, and medical professionals to ensure that new developments can be safely and effectively translated into clinical practice.

What Drives the Growth in the Biocompatible Materials Market?

The growth in the biocompatible materials market is driven by several factors, including technological advancements that allow for the development of more sophisticated and effective products. An aging global population and a corresponding increase in the prevalence of chronic diseases such as osteoarthritis and cardiovascular diseases are also significant growth drivers, as these conditions often require long-term implantable devices and surgical interventions. Additionally, the increasing demand for minimally invasive surgeries promotes the use of biocompatible materials that can be delivered through smaller incisions and offer quicker recovery times and reduced risk of infection. Consumer behavior is also evolving, with patients increasingly seeking treatments that improve not only longevity but also quality of life, which biocompatible materials can offer. Moreover, regulatory support for biocompatible materials in emerging markets is expanding access to novel medical technologies, further stimulating growth in the industry. These factors collectively ensure that the market for biocompatible materials continues to expand, providing essential solutions for a broad range of medical applications.

Select Competitors (Total 53 Featured) -

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â